Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Paul Hartmann AGFRA:PHH2 +0.75%64 Dividend Payout Ratio is 0.52 as of Jun. 2026, which is 68% above its 10-year median of 0.31. GuruFocus rates FRA:PHH2 with a GF Score™ of 64/100 and a GF Value™ of €226.94 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 288 Medical Devices & Instruments companies, Paul Hartmann AG ranks better than 71.87% on this metric.
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Paul Hartmann AG's Dividend Payout Ratio for the
months ended in Jun. 2026 was 0.52.
The historical rank and industry rank for Paul Hartmann AG's Dividend Payout Ratio or its related term are showing as below:
FRA:PHH2'
s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.23 Med: 0.31 Max: 1.04
Current: 0.28
During the past 13 years, the highest Dividend Payout Ratio of Paul Hartmann AG was 1.04. The lowest was 0.23. And the median was 0.31.
FRA:PHH2's Dividend Payout Ratio is ranked better than 71.87% of 288
companies
in the Medical Devices & Instruments industry
Industry Median: 0.425
vs FRA:PHH2: 0.28
During the past 5 years, the average Dividends Per Share Growth Rate was 1.90% per year.
During the past 10 years, the average Dividends Per Share Growth Rate was 2.30% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Paul Hartmann AG was 15.20% per year. The lowest was 0.00% per year. And the median was 4.60% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Paul Hartmann AG (FRA:PHH2) Dividend Payout Ratio Explanation
In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Paul Hartmann AG Dividend Payout Ratio Related Terms
Paul Hartmann AG Dividend Payout Ratio Historical Data
* Premium members only.
The historical data trend for Paul Hartmann AG's Dividend Payout Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:PHH2 vs ISRG, BDX, MDLN: Dividend Payout Ratio Comparison
For the Medical Instruments & Supplies subindustry, Paul Hartmann AG's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Paul Hartmann AG Dividend Payout Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Paul Hartmann AG's Dividend Payout Ratio distribution charts can be found below:
* The bar in red indicates where Paul Hartmann AG's Dividend Payout Ratio falls into.
Paul Hartmann AG Dividend Payout Ratio Calculation
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.
Paul Hartmann AG's Dividend Payout Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Paul Hartmann AG (FRA:PHH2) has a Dividend Payout Ratio of 0.52 as of Jun. 2026. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Paul Hartmann AG and its competitors. This is 68% above median its historical median of 0.31. Over the past decade, Paul Hartmann AG's Dividend Payout Ratio has ranged from 0.23 to 1.04. According to the industry distribution chart, Paul Hartmann AG ranks #81 out of 288 companies in the Medical Devices & Instruments industry, placing it in the top 28.1%.
Is Paul Hartmann AG's Dividend Payout Ratio too high?
Paul Hartmann AG's current Dividend Payout Ratio of 0.52 is 68% above median its 10-year median of 0.31. Over the past 10 years, this metric has ranged from a low of 0.23 to a high of 1.04. The Medical Devices & Instruments industry median Dividend Payout Ratio is 0.43. Paul Hartmann AG's value of 0.52 is 22.4% above this industry median. Based on the distribution chart, Paul Hartmann AG ranks #81 out of 288 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Paul Hartmann AG has a GF Score™ of 64/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Paul Hartmann AG's Dividend Payout Ratio compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Paul Hartmann AG ranks #81 out of 288 companies for Dividend Payout Ratio. This puts Paul Hartmann AG in the upper half of its industry. The industry median Dividend Payout Ratio is 0.43. Paul Hartmann AG's value of 0.52 is 22.4% above this benchmark. Historically, Paul Hartmann AG's own Dividend Payout Ratio has ranged from 0.23 to 1.04 over the past decade. While the company's 10-year median is 0.31 vs. the industry median of 0.43, Paul Hartmann AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Payout Ratio for a Medical Devices & Instruments company?
The median Dividend Payout Ratio among Medical Devices & Instruments companies is 0.43, based on 288 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Payout Ratio significantly above this median, while those in the bottom quartile fall well below. However, Dividend Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Paul Hartmann AG's current Dividend Payout Ratio of 0.52 is 22.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Payout Ratio mean?
A high Dividend Payout Ratio can signal that a stock is expensive relative to its fundamentals. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Paul Hartmann AG and its competitors. For the Medical Devices & Instruments industry, the median Dividend Payout Ratio is 0.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Paul Hartmann AG's current Dividend Payout Ratio is 0.52, which is 68% above median its own 10-year median of 0.31. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Paul Hartmann AG stock overvalued right now?
Based on GuruFocus' analysis, Paul Hartmann AG (FRA:PHH2) is currently considered Modestly Undervalued. The stock's GF Value™ is €226.94, compared to a current price of €201.00 — trading 11.4% below its estimated fair value. The current Dividend Payout Ratio is 0.52, which is 68% above median its 10-year median of 0.31 and 22.4% above the Medical Devices & Instruments industry median of 0.43. Paul Hartmann AG's overall GF Score™ is 64/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Payout Ratio calculated?
Dividend Payout Ratio is calculated from a company's financial statements. For Paul Hartmann AG (FRA:PHH2), the current Dividend Payout Ratio is 0.52 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Paul Hartmann AG (FRA:PHH2) Overvalued in 2026?
Based on GuruFocus' analysis, Paul Hartmann AG stock appears to be undervalued.
The current stock price of €201.00 is trading 11.4% below its estimated GF Value™ of €226.94.
GuruFocus considers Paul Hartmann AG to be Modestly Undervalued.
Key valuation signals for FRA:PHH2:
Dividend Payout Ratio: 0.52 (68% above median its 10-year median of 0.31)
GF Value™: €226.94 vs. price of €201.00 (11.4% below fair value)
Industry Position: 22.4% above the Medical Devices & Instruments median (#81 of 288)
No single metric tells the full story. See the FRA:PHH2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Paul Hartmann AG engages in the production of medical and hygiene products. It operates through Wound Management, Incontinence Management and Infection Management and other segments. The Wound segment comprises wound dressing and treatment, compression therapy, first aid, immobilization, and diagnostics. The Incontinence segment provides incontinence hygiene, patient care, and medical skin care. The Infection segment consists of custom procedure trays, surgical draping systems, disposable surgical instruments, and disinfectants. The Other activities include activities in cotton-wool products, medical consumer goods and pharmaceutical products and others. All the activities are functioned through the region of US and derive revenue through the sale of medical and hygiene products.
64GF Score
Get the complete analysis for FRA:PHH2
Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:PHH2 has been successfully added to your 
